Introduction
Direct consequences of chronic high glucose levels are believed to play a major role in the pathogenesis of diabetic complications (1) . One of them is protein glycation. In this reaction, glucose and other sugars react non-enzymatically with a wide range of proteins to form early glycation products, initially a Schiff base which undergoes a rearrangement to ketoamine (1) (2) (3) . On long-lived proteins such as collagen, crystallins, myelin, and probably nucleoproteins, a complex series of rearrangements and oxidative reactions ensues, leading to the formation of multiple, very reactive species collectively named advanced glycation endproducts or AGEs (1, (4) (5) (6) . These adducts are heterogeneous in structure and their precise chemical nature is under investigation. Some of the naturally occurring AGES have been isolated and their chemical structure elucidated (7) (8) (9) (10) (11) (12) (13) (14) (15) angial matrix were labeled. Probes having a higher content of AGES yielded more intense labeling. Control experiments demonstrated the specificity of the labeling obtained. Quantitative evaluation indicated little variation in reactivity among tissues from rats of different ages. However, a significant increase in reactivity was established for tissues from streptozotwin-induced long-term diabetic rats. This study thus provides direct evidence that soluble AGEs bind to cell nuclei and to structures implicated in the development of diabetic glomerular nephropathy, demonstrating higher AGE reactivity in tissues from diabetic animals. ( J Histochem Cytochem 43591400, 1995) KEY WORDS: Diabetes; Glycation; Colloidal gold cytochemistry; Glomerular basement membrane; Mesangium; Nucleus.
AGES accumulate in vivo on vascular wall collagen and basement membrane as a function of age and level of glycemia (4, 16, 17) . They are capable of producing cross-linking of proteins and have been shown to display diverse biological activities, including (a) increased endothelial cell permeability, (b) binding to receptors on macrophages and on endothelial and mesangial cells, (c) activation of macrophages and secretion of cytokines after AGE ligandreceptor interaction, and (d) quenching of nitric oxide with consequent inhibition of vascular dilatation (4, (18) (19) (20) (21) (22) (23) (24) . Through these and other properties, a considerable amount of evidence is growing for a causal relationship between AGE accumulation and the development of chronic diabetic complications. One of these, diabetic nephropathy leading to glomerulosclerosis, is responsible for kidney failure in 30-40% of diabetic patients. The development of new assays for AGEs has shown that they not only accumulate in tissues but circulate as well (4, 17, 20, (25) (26) (27) (28) . Particularly impressive are recent data showing a dramatic increase in the levels of circulating AGE peptides in diabetic endstage renal disease that correlates with the severity of the nephropathy (19, 20, 28) . In addition, short-term administration of exogenous AGE-modified albumin to otherwise normal rats and rabbits leads to the covalent attachment of these adducts to the extracellular matrix in several tissues (29) . Moreover, after this modification a range of vascular dysfunctions resembling those observed in diabetes occurs.
In t h e present study we have generated a probe that enables demonstration of the reactivity of AGES towards kidney tissue components. AGE-bovine serum albumin (AGE-BSA) was prepared and tagged with colloidal gold particles. We have characterized these probes and evaluated their reactivity towards glomerular tissue form control rats. In addition, t h e effect of age a n d diabetes on t h e reactivity of AGE-BSA probes towards renal tissues was investigated.
Materials and Methods

Preparation and Characterization of BSA Containing AGEs
Crystallized and lyophilized BSA, fraction V (Sigma; St Louis, MO) was glycated in vitro by incubation at 37°C for 15, 30, or 60 days in the presence of 1 mol/liter glucose in 0.5 mol/liter sodium phosphate buffer containing 1 mmollliter EDTA, 1 mmollliter phenylmethylsulfonyl fluoride (PMSF), 1 mmollliter aprotinin, and 1 mmollliter sodium azide. Protein concentration was 100 mg/ml and incubation was performed after sterilizing the solution by passage through a 0.2-pm Millipore membrane (Millipore Canada; Mississauga, Ontario, Canada). The AGE-BSA thus prepared was used for conjugation with colloidal gold particles. As a control, BSA was incubated in parallel under the same conditions but omitting glucose, and a BSA-gold complex was also generated. In addition, mildly glycated BSA (glcBSA, containing low amounts of early glycation products and no AGEs) was prepared by incubating BSA under the same conditions as above, except that glucose concentration was 100 mmollliter and incubation was carried out for only 3 days. The glcBSA was conjugated with gold particles.
The presence of AGEs in our probes, was confirmed by fluorometry using excitation at 370 nm and emission at 440 nm for total fluorescent AGEs and at 3351385 nm for pentosidine fluorescence, as previously described (5.25) . A Turner 430 spectrofluorometer (AMSCO Instruments: Carpinteria, CA) was employed for these measurements. Briefly, samples were adjusted to the same protein concentration (1 mglml) and an arbitrary value of 1 was assigned to the fluorescence of control BSA. The fluorescence of modified BSA was related to this reference value. The second criterion employed to measure AGEs in BSA was their characteristic absorption spectrum (23) measured with a Shimadzu UV 160 U recording spectrometer (RPI Instruments; Montreal, Quebec, Canada) . Absorbance at 350 nm was related to absorbance at 280 nm to correct for protein concentration.
The degree of modification of lysine residues was monitored by the trinitrobenzene sulfonic acid assay (TNBSA) as previously described (30). Briefly, 50 pl of samples (1 mglml) was incubated with 1 m10.48 mmollliter NaHCO3 and 50 p1 3.3 mllliter TNBSA for 1 hr at 37°C. Absorbance at 340 nm of control (non-modified) samples was considered as 100% and percentage of modification in glycated samples calculated on this value.
Early glycation products were determined by the ketoamine-specific reduction of nitroblue tetrazolium as previously reported for purified proteins (31) .
The probes were also characterized by SDS-PAGE under non-denaturing conditions (32). Flatbed isoelectric focusing in 1% agarose using pH 3.5 to 10.0 Pharmalytes IEF equipment from Pharmacia (Uppsala, Sweden) was employed to measure the PI of our probes.
Conjugation of AGE-BSA and BSA to Gold Particles
Monodisperse gold sols were obtained starting from a 0.01% tetrachloroauric solution (BDH; Poole, UK) according to the method of Frens ( 3 3 ) to obtain 15-nm particles. Only one batch of this colloid was used throughout the experiments. The size distribution of these particles was analyzed as previously described (34).
Colloidal gold was stabilized with BSA, glcBSA, or AGE-BSA (reduced and non-reduced) on determination of the optimal conditions. Briefly, the minimal amount of ligand (BSA, glcBSA, reduced AGE-BSA, AGE-BSA) required to stabilize the gold sol was determined by titration (35.36): 100 pl of linearly diluted ligand was added to 1 ml of 7 mmollliter phosphatebuffered colloidal gold. A pH of 6.2 was used for BSA and a pH of 5.8 was employed for AGE-BSA. These were based on the change in PI observed in IEF because maximal binding and stability of the protein-gold complex are obtained at pH values slightly higher than the PI of the protein. To these dilutions, 100 pl of 10% NaCl was added and tubes were read at 520 nm. The minimal amount of protein that stabilized our gold sols was calculated from the first dilution in which there was no modification of absorbance compared with gold sols added up with water. This concentration was 160 pglml for BSA and 240 pglml for AGE-BSA. The concentration needed to stabilize colloidal gold was not significantly different among the three different degrees of AGE-BSA employed in our work. A 20% excess of this minimal amount was used to prepare our complexes. To the mixture of 15-nm gold particles and protein we added polyethylene glycol MW 20,000 (PEG) to a final concentration of 0.4 mglml. After stirring, the tubes were centrifuged in a 50 Ti rotor for 30 min at 60,000 x g in a Beckman XI Ultracentrifuge (Bioanalytical System Group; Mississauga, Ontario, Canada). The supernatant was carefully removed and the sediment was re-suspended in PBS containing 0.4 mg/ml PEG. Before incubation with tissue sections the probes were diluted in PBS to a final absorbance of 0.5 at 550 nm.
T' zssue~
Tissues from Adult Control Animals. Four male Sprague-Dawley rats aged 7-15 months were employed. After sacrifice of the animals by terminal anesthesia, small pieces of kidney were excised and fixed by immersion in 4% periodate-lysine-paraformaldehyde solution for 2 hr at 4°C. The tissue fragments were then processed for electron microscopy through methanol dehydration and embedded in Lowicryl K4M at -20°C as previously described (36,37). Thin sections were cut, mounted on nickel grids coated with Parlodion and carbon films, and processed through the labeling experiments.
Tissues from Young Control Animals. Renal tissue from four male Sprague-Dawley rats under 21 days of age was processed as described in the preceding paragraph.
Tissues from Diabetic Animals. An experimental hyperglycemic state was induced in male Sprague-Dawley rats, weighing 100 g, by a single I P injection of streptozotocin (70 mglkg body weight, dissolved in 10 mmollliter sodium citrate, pH 4.5) (37). Four animals maintained hyperglycemic for 7-15 months were studied. Four animals sham-injected with the same volume of sodium citrate were used as controls. None of the animals was treated with insulin. Urine samples were collected and analyzed weekly for the presence of glucose and ketone bodies as well as pH (reagent strip N-Multiplex; Ames, Ontario, Canada). The streptozotocin-injected animals exhibited glycosuria 24 hr after the injection, which remained positive throughout the experiments. Aciduria and ketonuria were also permanent features of these animals. When animals were sacrificed, the body weight of the streptozotocin-injected rats averaged 300 g vs 700 g for the control animals. Blood glucose (measured by the glucose oxidase method) and insulin (measured by radioimmunoassay) levels for diabetic animals averaged 37.5 f 8.3 mmol/liter and 22.8 e 6.8 pmol/liter, respectively, vs4.> f 1.0 mmoU liter and 115.0 e 30.0 pmollliter for the controls. After sacrifice by terminal anesthesia, kidney tissue was processed as described above. Kidney sec-tions from these animals displayed the characteristics of diabetic glomerulopathy as revealed by routine light and electron microscopy.
Labeling Protocol
Tissue sections were incubated for 5 min on a drop of 10 mmollliter PBS, pH 7.4, then were transferred to a drop of 10 g/liter BSA and incubated for 30 min at room temperature. Next, grids were incubated at 37°C for 30 min in a humidified chamber on a drop of the AGE-BSA-gold complex. The grids were washed by five successive floatings on PBS under stirring, then rinsed with distilled water and dried. Staining with uranyl acetate was performed before examination with a Philips 410 electron microscope.
Cytochemical Controls
In one type of control experiment the grids were incubated with BSA-gold instead of the AGE-BSA-gold. In the other control experiment, grids were allowed to react overnight with a 100-fold excess of either BSA or AGE-BSA at 37'C and then incubated with gold-labeled ligands.
Quantitation of the Labeling
A quantitative evaluation of the labeling intensity was performed for each probe over the glomerular basement membrane, the extracellular matrix of the mesangial area, and the glomerular cell nuclei. The quantitation was carried out on tissues from control animals to evaluate the differential effect of AGEs accumulation in BSA (AGEi5-BSA-gold, AGE~o-BSA-~OI~, AGEGO-BSA-gold). Next, AGE3o-BSA-gold was employed to study the effect of age and diabetes on AGE reactivity towards renal tissue. For study of the effects of age, tissues from four rats under 21 days of age were examined and compared to those of the 7-15-month-old animals. For study of the effects of diabetes, four long-term diabetic and four age-matched control rats were studied. For each structure and each animal, 10 microscopic fields were recorded on video at x 21.000 magnification and brought to a final magnification of x 105,000. The area of each of the compartments was evaluated by planimetry and then the gold particles present over these areas were counted.
The intensity of labeling, as expressed in number of gold particleslp2, was evaluated using a Carl Zeiss Videoplan electronic digitizer (Carl Zeiss; Toronto, Ontario, Canada).
Statistical Methods
Data are expressed as mean * SEM. Results were compared by the Student's t-test (two-tailed) for unpaired data.
Results
Biochemical Characterization of Advanced Glycated BSA Probes
The ligands were checked for early and late glycation products by a modified nitroblue tetrazolium technique, by characteristic fluorescence, and by spectrophotometric spectra. The number bf lysine residues modified was quantitated by the TNBSA reaction. PAGE electrophoresis and isoelectrofocusing were performed in all the preparations as well. Table 1 summarizes the biochemical characterization of the different probes used in this work. AGE-BSA (generated by incubation for 15, 30, or 60 days) contained AGEs producing the characteristic fluorescence and absorption spectra.
We used two fluorometric analyses, excitation emission at 335/385 nm and at 3701440 nm. The first detects mainly pentosidine-like products and the second is optimal for detection of most fluorescent AGE adducts. Pentosidine-like adducts appeared in AGE-BSA at 15 days and doubled at 30 days. Total fluorescent AGEs, in turn, increased 30 times in the same period. Reduction of AGE-BSA (60 days) led to a drastic decrease in early glycation products. Over 70% of lysine residues in the AGE molecules have been derivatized, as shown by direct measurement of amino groups still reactive. BSA glycated under milder conditions (100 mmollliter glucose, PBS, 3 days), leading to a degree of modification known to occur in some diabetic patients, contained no AGEs (Table 1) . PAGE under nondenaturing conditions (32) yielded a single band of 68 KD for BSA or glcBSA. AGE-BSA, regardless of the incubation time, showed a single band of 73 m. AGE-BSA incubated for 60 days contained, in addition, high molecular weight polymeric forms (not shown).
Cytochemical Studies
On incubation of tissue thin sections with AGE-BSA tagged with colloidal gold, a binding reactivity towards renal tissue components was apparent (Figures 1-3 ). Structures directly involved in diabetic glomerular nephropathy, such as mesangial matrix and glomerular basement membrane, reacted with the AGE probe. In addition, particularly intense labeling was observed over nuclei. Labeling of cell nuclei was essentially the same for epithelial, mesangial, and endothelial cells: 15.61 k 0.7, 12.25 * 1.8, and 14.4 2 0.8 gold particles/W*, respectively (X 2 SEM; n = 7). Cytoplasm, mitochondria, and other organelles showed little labeling, and red blood cells, urinary space, and capillary lumen were almost free of labeling. The reactivity was not due to BSA itself, since BSA-gold as well as glcBSA-gold did not yield any significant labeling (Figure 4a) . In addition, in the incubation protocol, grids were always pre-incubated for 30 min with a 100-fold concentration of BSA before the reaction with AGE-BSA-gold. In control conditions, the binding was specifically and significantly reduced by preincubation of the grids with a 100-fold excess of AGE-BSA but not with BSA ( Figure 4b) .
Effect of AGE Content of the Probes
The intensity of the labeling, as shown in Table 2 , was proportional to the accumulation of AGEs on the protein. Incubation of BSA with glucose for different periods led to molecules containing increasing amounts of AGE adducts (Table 1) . In this way, we produced AGE-BSA with three different degrees of modification by incubation with glucose for either 15, 30, or 60 days (AGEl>-BSA, AGE3o-BSA, and AGEGO-BSA). Each of these was coupled with colloidal gold and the three AGE-BSA-gold complexes were then used as probes. AGE6o-BSA-gold ( Figure 3 ) yielded much more intense labeling than AGE3o-BSA-gold (Figure 2) , and that labeling was, in turn, higher than that generated by AGEl>-BSA-gold ( Figure 1) .
Reduction of AGE-BSA with NaBH4 was accomplished to better discriminate the participation of early and late glycation products (coexisting in in vitro-prepared AGE-BSA) in the reaction of the ligand to cell and matrix structures. Reduction of ketoamines by NaBH4 led to a 30% decrease in reactivity towards nuclei in the case of AGE-BSA incubated for 15 days and only 10% for AGE-BSA incubated for 60 days. This demonstrates a small participation of early glycation products in the reactivity of our probes towards nuclei.
E f f t of Age of the Animals
To study the effect of the age of the animals on the reactivity of AGEs towards kidney tissue, we used AGE3o-BSA-gold on renal tissue sections from rats under 21 days of age and rats between 7 and 15 months old. A trend towards an increase in the labeling of glomerular basement membrane, mesangium, and nuclei of renal tissue from adult rats compared with young rats was observed. However, these differences were not statistically significant by the Student's t-test (Table 3) .
Effect of Diabetes
To study the effect of chronic hyperglycemia on the capacity of kidney tissue structures to react with AGEs, we compared labelings obtained on tissues from four 7-l>-month-old diabetic rats with those of four age-matched control rats. For these experiments we employed the AGE3o-BSA-gold probe. Table 3 shows that labeling by AGES is significantly increased in glomerular structures from diabetic rats compared with those of the age-matched controls. Glomerular basement membranes, mesangial matrix, and particularly nuclei displayed a 10-30% increase in labeling. Labeling of nuclei did not exhibit any difference among cell types. An important rise was also noticed when AGE6o-BSA-gold was employed, as illustrated in Figure 5 . In addition, mesangial matrix deposits, characteristic of diabetic renal tissues, appeared more intensely labeled ( Figure 5 ). BSA-gold did not generate any significant labeling on tissues from diabetic rats.
Discussion
Glycation of proteins leads to the formation of early and advanced glycation products. Structural and functional modifications of proteins as a result of these reactions have been extensively studied for the past 15 years (1) (2) (3) (4) (5) (6) . A role for these adducts, as well as for the oxidative products formed as a consequence, is becoming increasingly recognized as one of the molecular bases of diabetic longterm complications and aging. Several AGEs have been characterized, some produced in vitro and others isolated from tissues. However, it is becoming clear that a combination of AGES not yet fully characterized is likely to occur in vivo.
AGE-BSA is a model of a modified protein that has been employed in multiple studies looking for the effects generated by AGE products. Bucala et al. (23) demonstrated that AGE-BSA quenches nitric oxide and that formation of AGEs in diabetic rats correlates with impaired vasodilatation, a characteristic feature of diabetes. Using a similar model ([ '231]-AGE-rabbit albumin and [ lZ3I]-AGE-rat albumin and the biochemical detection of radioactivity in homogenates), Vlassara et al. (29) have recently demonstrated that AGES injected into otherwise healthy animals led to tissue accumulation and to changes in vascular tone paralleling those seen in diabetes. They showed that AGES can have deleterious effects per se, independent of the initial hyperglycemic insult. Circulating AGE peptides, which are cleared by the kidney, accumulate in renal failure and can produce the same effects even in non-diabetic subjects (19, 20) .
These exciting data prompted us to study at the ultrastructural level the reactivity of AGES towards renal tissue of control and diabetic rats by colloidal gold post-embedding electron microscopic cytochemistry. For this purpose, we generated an AGE probe with BSA, which we tagged with colloidal gold particles. Next, we examined the reactivity of the probe towards renal tissue from rats by means of the following experimental design: First, we studied the effect of AGEs concentration, using probes with increasing contents of AGEs and allowing them to react with normal renal tissues. Next, we compared the reactivity of AGE-BSA towards tissues from young and adult normal rats. Finally, we compared the reactivity of AGE-BSA towards tissues from long-term diabetic rats and their age-matched controls.
To study the effect of AGEs content on the reactivity of our . 6lcBSA. mildly glycated BSA probes, AGE-BSA with different degrees of modification was conjugated to colloidal gold particles. Three different complexes were prepared using AGE-BSA produced by incubation of BSA with glucose for 15, 30, or 60 days. The AGE-BSA thus generated contained AGEs that produced characteristic fluorescence and absorption spectra. Pentosidine-like adducts appeared in AGE-BSA at 15 days and doubled at 30 days. Total fluorescent AGEs, in turn, increased 30 times in the same period. Whereas total and pentosidine fluorescence reached a plateau at 30 days, chromogen products continued to accumulate and even doubled from Day 30 to Day 60. This shows that fluorescent products represent only a certain percentage of the AGE adducts and suggests that their concentration reaches an equilibrium, whereas other chromogenic products continued to accumulate. Early glycation products, on the other hand, showed a time-dependent parallel decrease, indicating their slow conversion into fluorescent and chromogenic AGEs. Over 70% of lysine residues in the AGE molecules have been derivatized, as shown by direct measurement of amino groups still reactive, suggesting that at least 40 lysine residues per albumin molecular have been modified. These data are also supported by the change in molecular weight found in SDS-PAGE, which showed a main band of 7 3 KD for AGE-BSA instead of the 68 KD band found for BSA or glcBSA. This change in molecular weight, due to the addition of glucose to the BSA molecule, is in agreement with the data of Lapolla et al. (38) , who studied BSA glycation by matrix-assisted laser desorption ionization mass spectrometry.
When AGE-BSA-gold probes were allowed to react with rat renal tissue sections, labeling by gold particles over different cell and tissue structures was apparent. Strong labeling was found over nuclei, and in the extracellular compartment, glomerular basement membranes and mesangial matrix displayed the signal. The capillary lumen and urinary spaces, on the other hand, were devoid of labeling. Red blood cells did not appear significantly labeled. These results were proven to be highly specific by the different control (23) reacted with structures directly implicated in diabetic glomerular nephropathy, such as mesangial matrix and glomerular basement membrane. In this sense, our work provides a direct evidence of the reaction of AGEs with these structures in vitro. This supports previous data showing accumulation of [ lZ51]-AGE albumin in glomerular homogenates after injection of the ligand into control rats (29) . It must be kept in mind that we used here a postembedding procedure. Therefore, the implications of these findings in the pathogenesis of diabetic glomerulosclerosis should be confirmed by further in vivo studies.
No significant difference in the labeling was found when tissues from rats under 21 days of age were compared with those from adult rats (over 7 months of age), although the labeling of all the structures studied showed a trend to be higher in adult rats. This suggests that binding of AGE-BSA-gold to tissue sections depends mainly on AGEs on the probe rather than on those in the tissue, since adult rats would be expected to have a higher content of the latter.
Binding of AGE-BSA-gold on tissues from diabetic rats was higher than that found with tissues from age-matched control animals. Several possible explanations for this issue can be put forward. First, the increased binding could be due to the presence of higher concentrations of endogenous (produced locally or deriving from the circulation) early and advanced glycation products in diabetic tissues, which could react with the AGEs of our probe. Indeed, several lines of evidence indicate that Type IV collagen and laminin, as well as other components of basement membranes, exhibit higher glycation in diabetic patients (4, 7) . However, the increase in extracellular matrix present in diabetic tissue cannot explain this rise, since quantitation of our labelings was determined as gold particles per surface unit; the amount of extracellular matrix should not affect the results. Furthermore, we must recall that these comparisons were made always using the same AGE-BSA-gold probe; AGE content in the probe will therefore not influence our comparative evaluation between control and diabetic tissues.
The finding of strong reaction of AGEs towards nuclear components raises the question of whether this represents a particular -GUGLIUCCI, BENDAYAN --. --. Figure 5 . Renal tissue from a diabetic rat, maintained hyperglycemic for 10 months. The section was incubated with AGEW-BSA-gold. Labeling is intense over the cell nuclei (N). The glomerular basement membrane (GBM) and the mesangial matrix (Mes). particularly the matrix deposits (*), are labeled. The capillary lumen (CL) and the urinary space (US) are free of labeling. Bar = 1 pm. receptivity of nuclear constituents or whether it reflects only the intense reactivity of glycation products. Relevant to this are the data from Kelly et al. (39) obtained by light immunocytochemistry, suggesting the presence of early glycation products in nuclei. Because glycation products are prone to react with each other, this could also provide an explanation for the increase in nuclear labeling found in diabetic rat tissues. Indeed, it has been previously demonstrated by that DNA can be easily glycated. Through in vitro experiments, they demonstrated that glycation of DNA has a profound and dramatic effect on transcription efficiency. Our findings demonstrate that glycation products can readily react with nuclear components and that, as expected, this reaction is not limited to the kidney but occurs in other tissues as well (unpublished observations). Several pathogenic implications stem from this observation. It is not impossible that glycation products are formed in long-lived proteins within the cell and the nucleus by the bias of the reaction of phosphorylated sugars with proteins or DNA. These sugars, although less concentrated than glucose in body fluids, are far more reactive than glucose (3, 4) . Glucose-6-phosphate, for example, can attain a concentration of 250 pmol/liter in normal cells (40), i.e., 5 % of normal blood glucose level, but, being almost 10-fold more reactive as a glycating agent than glucose, it could have a major impact on the formation of AGEs. Moreover, glyceraldehyde-3-phosphate, the most reactive glycation intermediate found to be elevated in diabetic cells, produces glycated proteins at a rate 200 times faster than glucose (41). Indeed, we have recently demonstrated through in vitro studies that histone octamers can easily accumulate AGEs when incubated with phosphorylated hexoses (42). Finally, intracellular AGE formation in a short-term period has in fact been recently demonstrated (43). In that study, the authors showed a sixfold rise in AGEs of basic fibroblast growth factor after only 1 week of cell culture in highglucose medium.
AGE-BSA contains, in addition to AGEs, early glycation products, as evidenced by the fructosamine reaction. Although it has been used in perfusion studies and the effects found were ascribed to its content of AGEs (29), we decided to explore whether early glycation products also participate in our binding. To answer this question, we prepared in parallel gold complexes with AGE-BSA and with AGE-BSA previously reduced with NaBH4, which eliminates ketoamines by transformation in glucytollysine (23). The reduction did not affect the reaction of the ligand with basement membranes or mesangial matrix. However, a significant reduction (30%) in binding to the nuclei was evidenced for AGEi>-BSAgold. This demonstrates that AGE-BSA binds to nuclear structures not only through its AGES but also through its early or intermediate glycation products. Participation of early glycation products was much less important (only 10%) in the case of AGE6o-BSA-gold, probably owing to the combined effects of their decreased concentration paralleled by the increment of more reactive AGE products in the same molecule. Glycated BSA (glcBSA-gold), which contained twice as many ketoamine linkages as control BSA, did not show any significant binding. Content of ketoamines was four times higher in AGEi>-BSA than in glcBSA, suggesting that a high concentration of these products is needed to produce the effect.
This last finding raised the possibility of the participation of nuclear lectins in the binding of early glycation products. The existence of nuclear lectins with affinities for glycoproteins produced by chemical addition of hexoses to proteins (neoglycoproteins) has been documented by several authors (44, 45) . In particular, BSA modified to contain 25 residues of hexoses has been used as a probe for cytochemical detection of lectins in nuclei (44). In spite of that, these lectins do not appear to be involved in our particular case, because most of our binding depends on AGEs and not on unmodified glucose residues, and also because the part of the binding in which participation of early glycation products is documented in our work depends on the existence of ketoamines. If this were not the case, reduction with NaBH4, which precisely converts the ketoamine in a glucytol residue, should not have any effect whatsoever. The neoglycoproteins employed in the above-mentioned articles do not contain ketoamines (45). Therefore, the radicals responsible for the binding are completely different in both cases. However, we cannot rule out the eventual presence of a different battery of lectins responsible for the binding of early glycation products to nuclear structures.
In conclusion, this study provides direct evidence that soluble advanced glycation endproducts bind to structures implicated in the development of diabetic glomerular nephropathy. These data give morphological support to previous reports showing renal accumulation of in vivo injected radiolabeled AGEs. In addition, we demonstrate that tissues from diabetic animals are more prone to react with soluble AGEs. Our data also suggest that if AGES are produced within the cell at increased rates in diabetic individuals, as has been documented in cell culture, they may bind to nucleoproteins and alter their function. Finally, our work identifies colloidal gold electron microscopy as yet another valuable tool to be employed as a complementary approach to ongoing studies on the pathogenetic action of glycated proteins.
